Additionally, the absence of ERα in MDA-MB-231 indicates that the enhanced transmigration activity triggered by E2 pretreatment is unlikely to be primarily due to ERα-mediated stimulation of cancer cells but rather can be attributed to estrogen interactions with endothelial cells and that non-genomic and ligand-independent signaling pathways may also be involved. This evidence concerns the gene ESR1 and cancer.